Featured Content

Articles

Existing Cancer Drug Shows Potential in Reactivating Immunotherapy

An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical University of Munich researchers have discovered a molecular mechanism that causes cancer cells to evade treatment and have shown that blocking it can make immunotherapy work again in some patients.  CAR-T cell therapy involves removing … Continue reading “Existing Cancer Drug Shows Potential in Reactivating Immunotherapy”

TinyGemsBreaks

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team

CNS Pharmaceuticals (NASDAQ: CNSP) announced that recently appointed President and CEO Rami Levin, in alignment with the board, has recruited Steven O’Loughlin as chief financial officer, Eric Faulkner as chief technology officer and Dylan Wenke as chief business officer, effective March 2, 2026. The company said the appointments support its strategic evolution following a comprehensive … Continue reading “TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team”

Sector News

Filter Releases
Sectors



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}

NewsRoom

Receive Alerts from TinyGems

Text "Gems" to 888-902-4192

(US Mobile Phones Only)

About TinyGems

Discover diamonds in the rough with TinyGems.

TinyGems spotlights emergent small-cap companies with bright futures and big potential. Small and yet unproven, there’s obvious risk but also huge upside possibilities for investors in the know. Contrary to conventional dogma, shares of small-cap and mid-cap companies posted far superior total returns than mega-cap stocks since December 1999.

Don’t overlook the innovation of disruptive small-cap companies on the cusp of market discovery. TinyGems puts a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios.

More About TinyGems    Schedule a Live Online Demo

Contact us: (512) 354-7000